StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Aristotle Test now $949 USD

<< Previous

Bullboard Posts

Next >>

Comment by LithLoveron Oct 04, 2022 5:39pm

126 Views

Post# 35005311

RE:RE:Aristotle Test now $949 USD

The Care Oncology piece is now pretty much cash flow positive. They had under $100k in cash at the end of June and only raised 170k for the quarter.

Given the company is nearly 100% supportive by Care Oncology looks like a renewed focus on Aristotle and the overall revenue for the company.

If they can make money on Aristotle (even at a lower amount) but it drives patients into the AVRT and COC protocals its a win for the patient and a win for revenue. The infrastructre for COC is now there so any new patients via Aristotle is all gravy.

Liked2Think wrote:

Tylerdude wrote: Recieved a email from Stage Zero this morning.

Aristotle is now $949 USD with testing available in Toronto Ontario, Van Nuys California, Gairthersubrg Maryland, Vernon Hills Illinois, Branchburg New Jersey, Coppell Texas and Richmon Virginia.

https://www.stagezerolifesciences.com/aristotle-enrollment.html

https://app.acuityscheduling.com/schedule.php?owner=20161544&appointmentType=28616162

Pumper patrol will label this as a "great decision as its more affordable and will therefore mean more tests"

Bashers will label this as "so they cant sell any tests and they think lowering the price will magically fix that"

What camp do you sit in?

One question though.
If they were selling tests at the previous cost why would they lower them in this day of age of high inflation and overall high costs of things. Makes you go hmmmmmm.